Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

44.35 +1.26 (+2.92%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	403,774
Open	43.15
Bid (Size)	41.98 (100)
Ask (Size)	45.40 (100)
Prev. Close	43.09
Today's Range	42.00 - 44.43
52wk Range	18.12 - 45.50
Shares Outstanding	71,726,685
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with Strong Technical Setup ↗

January 29, 2026

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the High-Growth Momentum and Trend Template Strategy ↗

December 13, 2025

KNSA stock meets Minervini's Trend Template with strong technicals and high-growth fundamentals, including surging EPS and revenue.

Via Chartmill

Performance

YTD	+5.6%	+5.6%
1 Month	+3.9%	+3.9%
3 Month	+12.3%	+12.3%
6 Month	+35.5%	+35.5%
1 Year	+126.3%	+126.3%

More News

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Combines Technical Strength and Fundamental Growth Momentum ↗

November 20, 2025

Via Chartmill

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

What to Expect from Kiniksa Pharmaceuticals's Earnings ↗

October 27, 2025

Via Benzinga

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Earnings Preview: Kiniksa Pharmaceuticals ↗

July 28, 2025

Via Benzinga

5 Analysts Have This To Say About Kiniksa Pharmaceuticals ↗

October 17, 2025

Via Benzinga

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Identified by High Growth Momentum and Minervini Trend Screen ↗

October 08, 2025

Via Chartmill

What Analysts Are Saying About Kiniksa Pharmaceuticals Stock ↗

September 29, 2025

Via Benzinga

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗

September 24, 2025

Via Chartmill

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity ↗

September 22, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate ↗

September 01, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential ↗

August 25, 2025

Via Chartmill

KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout ↗

August 22, 2025

Via Chartmill

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗

August 08, 2025

Via Chartmill

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Aligns with Minervini’s Trend Model as a Strong Momentum Pick ↗

August 05, 2025

Via Chartmill

Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

August 04, 2025

Via Benzinga

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗

August 04, 2025

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 25, 2025

Via Benzinga

Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth ↗

July 02, 2025

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

May 05, 2025

Via Benzinga

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Via Benzinga

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

April 30, 2025

From Kiniksa Pharmaceuticals, Ltd.

Via GlobeNewswire

Frequently Asked Questions

Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?

Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.

What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?

The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market

What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?

The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 44.35

When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?

The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 02/09/26 04:00 PM ET

What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?

The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 3.18B

How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.